The Ethics of living related liver transplantation when deceased donation is not an option
Thomas D. Schiano, Rosamond Rhodes – 9 December 2015
Noncirrhotic portal hypertension: Medical and endoscopic management
S. K. Sarin, Cyriac Abby Philips, Rajeev Khanna – 9 December 2015
The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?
Zobair M. Younossi – 9 December 2015
Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus‐Infected U.S. Women
Mark H. Kuniholm, Edgar Ong, Boris M. Hogema, Marco Koppelman, Kathryn Anastos, Marion G. Peters, Eric C. Seaberg, Yue Chen, Kenrad E. Nelson, Jeffrey M. Linnen – 8 December 2015 – Exposure to hepatitis E virus (HEV) is common in the United States, but there are few data on prevalence of HEV/human immunodeficiency virus (HIV) coinfection in U.S. populations. We tested 2,919 plasma samples collected from HIV‐infected (HIV+) women and men enrolled in U.S. cohort studies for HEV viremia using a high‐throughput nucleic acid testing (NAT) platform.
Association between systemic inflammatory response syndrome and mortality in alcoholic hepatitis: A meta‐analysis
Veeravich Jaruvongvanich, Sikarin Upala, Anawin Sanguankeo – 8 December 2015
Macrophage recruitment by fibrocystin‐defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis
Luigi Locatelli, Massimiliano Cadamuro, Carlo Spirlì, Romina Fiorotto, Silvia Lecchi, Carola Maria Morell, Yury Popov, Roberto Scirpo, Maria De Matteis, Mariangela Amenduni, Andrea Pietrobattista, Giuliano Torre, Detlef Schuppan, Luca Fabris, Mario Strazzabosco – 8 December 2015 – Congenital hepatic fibrosis (CHF) is a disease of the biliary epithelium characterized by bile duct changes resembling ductal plate malformations and by progressive peribiliary fibrosis, in the absence of overt necroinflammation.
Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15‐year follow‐up
Philip R. Spradling, Lisa R. Bulkow, Susan E. Negus, Chriss Homan, Michael G. Bruce, Brian J. McMahon – 5 December 2015 – The effect of passively transferred maternal antibody to hepatitis A virus (anti‐HAV) on the duration of seropositivity after hepatitis A vaccination during infancy and early childhood is unclear.
Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice
Denada Dibra, Xueqing Xia, Abhisek Mitra, Jeffry J. Cutrera, Guillermina Lozano, Shulin Li – 5 December 2015 – The cellular and molecular etiology of unresolved chronic liver inflammation remains obscure. Whereas mutant p53 has gain‐of‐function properties in tumors, the role of this protein in liver inflammation is unknown.
Retinoid regulation of antiviral innate immunity in hepatocytes
Noell E. Cho, Bo‐Ram Bang, Purnima Gurung, Meng Li, Dahn L. Clemens, T. Michael Underhill, Laura P. James, Jenifer R. Chase, Takeshi Saito – 5 December 2015 – Persistent infection of hepatitis C virus (HCV) is one of the leading causes of end‐stage liver disease (ESLD), such as decompensated cirrhosis and liver cancer. Of particular note, nearly half of HCV‐infected people in the United States are reported to be heavy drinkers. This particular group of patients is known to rapidly progress to the ESLD.